======= BMPER ======= == Gene Information == * **Official Symbol**: BMPER * **Official Name**: BMP binding endothelial regulator * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=168667|168667]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N8U9|Q8N8U9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BMPER&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BMPER|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608699|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a secreted protein that interacts with, and inhibits bone morphogenetic protein (BMP) function. It has been shown to inhibit BMP2- and BMP4-dependent osteoblast differentiation and BMP-dependent differentiation of the chondrogenic cells. Mutations in this gene are associated with a lethal skeletal disorder, diaphanospondylodysostosis. [provided by RefSeq, Dec 2011]. * **UniProt Summary**: Inhibitor of bone morphogenetic protein (BMP) function, it may regulate BMP responsiveness of osteoblasts and chondrocytes. {ECO:0000269|PubMed:14766204}. |VWC| |C8| |VWD| |TIL| |blood vessel endothelial cell proliferation involved in sprouting angiogenesis| |endothelial cell activation| |endothelial cell proliferation| |positive regulation of sprouting angiogenesis| |negative regulation of BMP signaling pathway| |sprouting angiogenesis| |regulation of pathway-restricted SMAD protein phosphorylation| |regulation of sprouting angiogenesis| |ureteric bud development| |mesonephric tubule development| |mesonephric epithelium development| |epithelial cell proliferation| |regulation of BMP signaling pathway| |mesonephros development| |negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |kidney epithelium development| |negative regulation of cellular response to growth factor stimulus| |regulation of endothelial cell migration| |positive regulation of angiogenesis| |positive regulation of vasculature development| |inner ear development| |positive regulation of ERK1 and ERK2 cascade| |regulation of epithelial cell migration| |ear development| |regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |kidney development| |regulation of cellular response to growth factor stimulus| |renal system development| |regulation of angiogenesis| |regulation of ERK1 and ERK2 cascade| |angiogenesis| |urogenital system development| |regulation of vasculature development| |blood vessel morphogenesis| |blood vessel development| |vasculature development| |cardiovascular system development| |positive regulation of MAPK cascade| |sensory organ development| |cell population proliferation| |tube morphogenesis| |regulation of MAPK cascade| |tube development| |regulation of cell migration| |circulatory system development| |anatomical structure formation involved in morphogenesis| |regulation of cell motility| |regulation of locomotion| |regulation of cellular component movement| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |regulation of anatomical structure morphogenesis| |cell activation| |epithelium development| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |positive regulation of protein modification process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |regulation of protein phosphorylation| |regulation of phosphorylation| |extracellular space| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp481|Ethambutol 25μM R08 exp481]]|-1.77| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-1.76| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|1.72| |[[:results:exp93|DABN racemic mixture R03 exp93]]|2.14| |[[:results:exp111|R-DABN 8μM R03 exp111]]|2.35| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.52| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.72| |[[:results:exp33|Rotenone 2μM R00 exp33]]|3.46| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|3.49| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|3.51| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|4.74| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13285 * **Expression level (log2 read counts)**: 1.47 {{:chemogenomics:nalm6 dist.png?nolink |}}